Marco Trevenzoli
- Infectious Diseases top 5%
- Epidemiology
- Oncology
- Surgery
- Virology top 5%
- Co-authors
- Anna Maria CattelanP CadrobbiLolita SassetSavina AversaGiovanni CarrettaMassimiliano LanzafameS. MonfardiniElke Erne
- Topics
- Viral-associated cancers and disorders (7 papers)COVID-19 Clinical Research Studies (4 papers)Drug-Induced Adverse Reactions (3 papers)
- Journals
- The LancetClinical Infectious DiseasesInternational Journal of Environmental Research and Public Health
- Partner nations
- ItalyUnited Kingdom
In The Last Decade
Marco Trevenzoli
32 papers receiving 582 citations
Peers
Comparison fields: 5 of 82
- Infectious Diseases 269
- Epidemiology 222
- Oncology 151
- Surgery 90
- Virology 89
Countries citing papers authored by Marco Trevenzoli
This map shows the geographic impact of Marco Trevenzoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Trevenzoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Trevenzoli more than expected).
Fields of papers citing papers by Marco Trevenzoli
This network shows the impact of papers produced by Marco Trevenzoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Trevenzoli. The network helps show where Marco Trevenzoli may publish in the future.
Co-authorship network of co-authors of Marco Trevenzoli
This figure shows the co-authorship network connecting the top 25 collaborators of Marco Trevenzoli. A scholar is included among the top collaborators of Marco Trevenzoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Trevenzoli. Marco Trevenzoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 31 | |
| 3 | 7 | |
| 4 | 5 | |
| 5 | 8 | |
| 6 | 32 | |
| 7 | 19 | |
| 8 | 8 | |
| 9 | 2 | |
| 10 | 30 | |
| 11 | 47 | |
| 12 | 6 | |
| 13 | Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report. | 1 |
| 14 | 31 | |
| 15 | 38 | |
| 16 | 11 | |
| 17 | 34 | |
| 18 | 12 | |
| 19 | 16 | |
| 20 | 50 |
About Marco Trevenzoli
Marco Trevenzoli is a scholar working on Infectious Diseases, Virology and Applied Microbiology and Biotechnology, having authored 33 papers that have together received 601 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (7 papers), COVID-19 Clinical Research Studies (4 papers) and Drug-Induced Adverse Reactions (3 papers). The work is most often cited by research in Virology (89 citations), Infectious Diseases (269 citations) and Applied Microbiology and Biotechnology (16 citations). Marco Trevenzoli has collaborated with scholars based in Italy and United Kingdom. Frequent co-authors include Anna Maria Cattelan, P Cadrobbi, Lolita Sasset, Savina Aversa, Giovanni Carretta, Massimiliano Lanzafame, S. Monfardini, Elke Erne, Luigi Salvagno and Giuseppe Luigi Banna. Their work appears in journals such as The Lancet, Clinical Infectious Diseases and International Journal of Environmental Research and Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.